Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation
Search: search_blue_button Advanced Search
Published Online
on July 19, 2004

Circulation. 2004
Published online before print July 19, 2004, doi: 10.1161/01.CIR.0000137969.87365.05
A more recent version of this article appeared on October 19, 2004
This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
110/16/2484    most recent
01.CIR.0000137969.87365.05v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Luo, J.-D.
Right arrow Articles by Chen, A. F.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Luo, J.-D.
Right arrow Articles by Chen, A. F.
Right arrowPubmed/NCBI databases
*Compound via MeSH
*Substance via MeSH
Medline Plus Health Information
*Genes and Gene Therapy
Hazardous Substances DB
*GLUCOSE
*NITRIC OXIDE
Related Collections
Right arrow Cardiovascular Pharmacology
Right arrow Angiogenesis
Right arrow Animal models of human disease
Right arrow Type 1 diabetes
Right arrow Gene therapy
Right arrow Oxidant stress
Right arrow Endothelium/vascular type/nitric oxide

Submitted on December 11, 2002
Revised on June 3, 2004
Accepted on June 14, 2004

Gene Therapy of Endothelial Nitric Oxide Synthase and Manganese Superoxide Dismutase Restores Delayed Wound Healing in Type 1 Diabetic Mice

Jian-Dong Luo MD, PhD, Ying-Ying Wang MD, Wei-Ling Fu MD, PhD, Jun Wu MD, PhD, and Alex F. Chen MD, PhD*

From the Departments of Pharmacology and Neurology and the Neuroscience Program (J.-D.L., Y.-Y.W., A.F.C.), Michigan State University, East Lansing; Department of Pharmacology, Guangzhou Medical College, Guangzhou, China (J.-D.L.); and Southwestern Hospital, Third Military Medical University, Chongqing, China (Y.-Y.W., W.-L.F., J.W., A.F.C.).

* To whom correspondence should be addressed. E-mail: chenal{at}msu.edu.

Background--Nitric oxide (NO) deficiency contributes to diabetic wound healing impairment. The present study tested the hypothesis that increased cutaneous superoxide (O2-) levels in type 1 diabetic mice cause NO deficiency and delayed wound healing.

Methods and Results--Wound healing was markedly delayed in streptozotocin-induced type 1 diabetic mice compared with the normal controls. There were significantly reduced levels of endothelial NO synthase (eNOS) protein and constitutive NOS activity in diabetic wounds, whereas O2- levels were markedly increased. A single regimen of cutaneous gene therapy of eNOS or manganese superoxide dismutase (MnSOD) restored such healing delay, with a concomitant suppression of wound O2- levels and augmentation of both eNOS protein and constitutive NOS activity. Gene therapy of MnSOD also increased cutaneous MnSOD activity. Cutaneous O2- levels were also increased in Ins2Akita diabetic mice. In vitro glucose treatment of cutaneous tissues from normal mice for 24 hours increased O2- levels in a concentration-dependent manner. The enhanced cutaneous O2- levels induced by high glucose in both normal and diabetic mice were abolished by the NADPH oxidase inhibitor apocynin and the protein kinase C inhibitor chelerythrine. Furthermore, ex vivo gene transfer of dominant-negative HA-tagged N17Rac1, which inhibits NADPH oxidase subunit Rac1, significantly inhibited cutaneous O2- formation induced by high glucose in both normal and Ins2Akita diabetic mice.

Conclusions--These results indicate that hyperglycemia augments cutaneous O2- levels, at least in part, via NADPH oxidase and protein kinase C pathways, resulting in impaired wound healing in type 1 diabetic mice. Gene therapy strategies aimed at restoring cutaneous NO bioavailability may provide an effective means to ameliorate delayed diabetic wound healing.


Key words: wound healing • nitric oxide • superoxides • diabetes mellitus • gene therapy




This article has been cited by other articles:


Home page
Am. J. Physiol. Renal Physiol.Home page
J. Yang, P. H. Lane, J. S. Pollock, and P. K Carmines
PKC-dependent superoxide production by the renal medullary thick ascending limb from diabetic rats
Am J Physiol Renal Physiol, November 1, 2009; 297(5): F1220 - F1228.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Endocrinol. Metab.Home page
J.-D. Luo, T.-P. Hu, L. Wang, M.-S. Chen, S.-M. Liu, and A. F. Chen
Sonic hedgehog improves delayed wound healing via enhancing cutaneous nitric oxide function in diabetes
Am J Physiol Endocrinol Metab, August 1, 2009; 297(2): E525 - E531.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Endocrinol. Metab.Home page
L. Tie, X.-J. Li, X. Wang, K. M. Channon, and A. F. Chen
Endothelium-specific GTP cyclohydrolase I overexpression accelerates refractory wound healing by suppressing oxidative stress in diabetes
Am J Physiol Endocrinol Metab, June 1, 2009; 296(6): E1423 - E1429.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Pathol.Home page
Y. Kanetsuna, K. Takahashi, M. Nagata, M. A. Gannon, M. D. Breyer, R. C. Harris, and T. Takahashi
Deficiency of Endothelial Nitric-Oxide Synthase Confers Susceptibility to Diabetic Nephropathy in Nephropathy-Resistant Inbred Mice
Am. J. Pathol., May 1, 2007; 170(5): 1473 - 1484.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
D.-D. Chen and A. F. Chen
CuZn Superoxide Dismutase Deficiency: Culprit of Accelerated Vascular Aging Process
Hypertension, December 1, 2006; 48(6): 1026 - 1028.
[Full Text] [PDF]


Home page
IOVSHome page
R. A. Kowluru, L. Atasi, and Y.-S. Ho
Role of mitochondrial superoxide dismutase in the development of diabetic retinopathy.
Invest. Ophthalmol. Vis. Sci., April 1, 2006; 47(4): 1594 - 1599.
[Abstract] [Full Text] [PDF]